In yesterday’s Wall Street session, Cardinal Health Inc. (NYSE:CAH) shares traded at $91.69, down -0.80% from the previous session.
17 analysts cover Cardinal Health Inc. (NYSE:CAH), according to research data. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $107.00 and a low of $78.00, we find $93.50. Given the previous closing price of $92.43, this indicates a potential upside of 1.16 percent. CAH stock price is now 2.24% away from the 50-day moving average and 14.33% away from the 200-day moving average. The market capitalization of the company currently stands at $23.53B.
The stock has received a hold rating from 12 analysts and a buy rating from 3. Brokers who have rated the stock have averaged $94.08 as their price target over the next twelve months.
With the price target maintained at $100, Evercore ISI recently Downgraded its rating from Outperform to In-line for Cardinal Health Inc. (NYSE: CAH).
In other news, Brennan Michelle, Director bought 200 shares of the company’s stock on Nov 15. The stock was bought for $14,944 at an average price of $74.72. Upon completion of the transaction, the Director now directly owns 3,324 shares in the company, valued at $0.3 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 14, Director Brennan Michelle bought 200 shares of the business’s stock. A total of $15,260 was incurred on buying the stock at an average price of $76.30. This leaves the insider owning 3,124 shares of the company worth $0.29 million. Insiders disposed of 373,455 shares of company stock worth roughly $34.24 million over the past 1 year. A total of 0.60% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in CAH stock. A new stake in Cardinal Health Inc. shares was purchased by POINT72 ASSET MANAGEMENT, L.P. during the first quarter worth $70,201,000. JUPITER ASSET MANAGEMENT LTD invested $23,529,000 in shares of CAH during the first quarter. In the first quarter, LIONTRUST INVESTMENT PARTNERS LLP acquired a new stake in Cardinal Health Inc. valued at approximately $20,493,000. ORIBEL CAPITAL MANAGEMENT, LP acquired a new stake in CAH for approximately $18,366,000. EXODUSPOINT CAPITAL MANAGEMENT, LP purchased a new stake in CAH valued at around $15,298,000 in the second quarter. In total, there are 1,287 active investors with 93.00% ownership of the company’s stock.
On Friday morning Cardinal Health Inc. (NYSE: CAH) stock kicked off with the opening price of $92.52. During the past 12 months, Cardinal Health Inc. has had a low of $57.30 and a high of $95.10. According to the stock market information, the enterprise value for the company is $24.09B, which is based on a 52.45 price-to-earnings ratio, a 3.67 price-to-earnings-growth ratio, and a beta of 0.80. The fifty day moving average price for CAH is $89.80 and a two-hundred day moving average price translates $80.31 for the stock.
The latest earnings results from Cardinal Health Inc. (NYSE: CAH) was released for Mar, 2023. According to the Medical Distribution Company, earnings per share came in at $1.74, beating analysts’ expectations of $1.49 by 0.25. This compares to -$5.05 EPS in the same period last year. The net profit margin was 0.20% and return on equity was -26.80% for CAH. The company reported revenue of $50.49 billion for the quarter, compared to $44.84 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 12.6 percent. For the current quarter, analysts expect CAH to generate $52.72B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 07/15/2023. Investors who held shares on 07/03/2023 were paid a $0.5006 dividend. On an annualized basis, this represents a $2.00 dividend and a 2.18% percent yield. There was an ex-dividend date of 06/30/2023 for this dividend. In terms of dividend payout ratio, CAH is presently at 112.30%.
Cardinal Health Inc.(CAH) Company Profile
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
